ArticleThe Kaohsiung journal of medical sciences2025
RETRACTION: Paris Saponin VII Enhanced the Sensitivity of HepG2/ADR Cells to ADR via Modulation of PI3K/AKT/MAPK Signaling Pathway.
Article in The Kaohsiung journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionG.-E. Tang, Y.-X. Niu, Y. Li, C.-Y. Wu, X.-Y. Wang and J. Zhang, "Paris Saponin VII Enhanced the Sensitivity of HepG2/ADR Cells to ADR via Modulation of PI3K/AKT/MAPK Signaling Pathway," The Kaohsiung Journal of Medical Sciences 36, no. 2 (2020): 98-106, https://doi.org/10.1002/kjm2.12145. The above article, published online on 05 November 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between; the journal Editor-in-Chief, Wan-Long Chuang; Kaohsiung Medical University; and John Wiley and Sons Australia. The retraction has been agreed upon due to elements in Figures 4A and 6C, which were found duplicated in other articles published earlier elsewhere, and in some cases representing a different scientific context. The authors did not respond to the concerns raised. The editors have lost confidence in the data presented and consider the conclusions to be substantially compromised. The authors were informed of the retraction but were unavailable for comment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.